Diastolic dysfunction in patients with overlap syndrome – An early sign of a high cardiovascular risk?

A. Moll, S. Rack, A. Moeller, C. Teupe (Frankfurt, Germany)

Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Session: Pulmonary circulation: clinical pulmonary hypertension II
Session type: Thematic Poster Session
Number: 2650
Disease area: Pulmonary vascular diseases, Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Moll, S. Rack, A. Moeller, C. Teupe (Frankfurt, Germany). Diastolic dysfunction in patients with overlap syndrome – An early sign of a high cardiovascular risk?. Eur Respir J 2013; 42: Suppl. 57, 2650

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD and OSA: Can the overlap syndrome be suspected by clinical symptoms
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016


Obesity hypoventilation syndrome with chronic respiratory insufficency versus chronic obstructive pulmonary disease with obesity: Similar versus nonsimilar characteristics
Source: International Congress 2016 – Latest insights into chronic care
Year: 2016


Prevalence of overlap syndrome and its correlation with severity of obstructive sleep apnea syndrome
Source: International Congress 2015 – Monitoring sleep-disordered breathing in children and adults
Year: 2015


A study on the association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016

Is there a strong relationship between COPD and cardiovascular diseases?
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013

Left heart dysfunction in COPD- Ignored combination
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013


Cardiovascular, metabolic prognosis and mortality of the positional sleep apnea syndrome: An historical cohort study including 240 patients
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Metabolic syndrome in patients with COPD and their association with systemic inflammation
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015


Long term effects of compliance with positive airway pressure (PAP) therapy in patients with obesity hypoventilation syndrome (OHS)
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016

Is metabolic syndrome a significant comorbidity in mustard lung patients?
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013

PAP therapy impact on COPD exacerbations rate in patients with overlap syndrome
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015

The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA)
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016


Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013


Correlation between red cell distribution width and disease severity and mortality in COPD patients
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Obesity hypoventilation syndrome and neurocognitive function - impact of positive airway pressure therapy
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018


Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014


Is there benefit from proactive case-detection of left ventricular systolic dysfunction (LVSD) using BNP in patients with advanced COPD?
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Renal function impairment and prediction of sleep apnea in patients with high cardiovascular risk
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020


Obstructive sleep apnea syndrome as factor of arrhythmic syndrome emergence and increase of cardiovascular risk in patients with COPD
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013

The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016